140 related articles for article (PubMed ID: 9519863)
1. Flow cytometric analysis of cellular changes in mice after intradermal inoculation with a liposome-iscom adjuvanted vaccine.
San Gil F; Turner B; Mullbacher A; Walker MJ; Djordjevic SP; Eamens GJ; Chin JC
Scand J Immunol; 1998 Mar; 47(3):243-53. PubMed ID: 9519863
[TBL] [Abstract][Full Text] [Related]
2. Contribution of adjuvant to adaptive immune responses in mice against Actinobacillus pleuropneumoniae.
San Gil F; Turner B; Walker MJ; Djordjevic SP; Chin JC
Microbiology (Reading); 1999 Sep; 145 ( Pt 9)():2595-2603. PubMed ID: 10517613
[TBL] [Abstract][Full Text] [Related]
3. Skin delivery of a hybrid liposome/ISCOM vaccine implicates a role for adjuvants in rapid modulation of inflammatory cells involved in innate immunity before the enhancement of adaptive immune responses.
Chin J; San Gil F
Immunol Cell Biol; 1998 Jun; 76(3):245-55. PubMed ID: 9682968
[TBL] [Abstract][Full Text] [Related]
4. Immune responses of a liposome/ISCOM vaccine adjuvant against streptococcal fibronectin binding protein 1 (Sfb1) in mice.
McArthur J; Schulze K; Chin J; Currie BJ; Sriprakash KS; Talay SR; Chhatwal GS; Guzmán CA; Walker MJ
Indian J Med Res; 2004 May; 119 Suppl():115-20. PubMed ID: 15232175
[TBL] [Abstract][Full Text] [Related]
5. Manipulating systemic and mucosal immune responses with skin-deliverable adjuvants.
Chin J; San Gil F; Novak M; Eamens G; Djordjevic S; Simecka J; Duncan J; Mullbacher A
J Biotechnol; 1996 Jan; 44(1-3):13-9. PubMed ID: 8717381
[TBL] [Abstract][Full Text] [Related]
6. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
[TBL] [Abstract][Full Text] [Related]
7. Characterization of hepatitis C virus core-specific immune responses primed in rhesus macaques by a nonclassical ISCOM vaccine.
Polakos NK; Drane D; Cox J; Ng P; Selby MJ; Chien D; O'Hagan DT; Houghton M; Paliard X
J Immunol; 2001 Mar; 166(5):3589-98. PubMed ID: 11207320
[TBL] [Abstract][Full Text] [Related]
8. Active immunization with a detoxified endotoxin vaccine protects against lethal polymicrobial sepsis: its use with CpG adjuvant and potential mechanisms.
Opal SM; Palardy JE; Chen WH; Parejo NA; Bhattacharjee AK; Cross AS
J Infect Dis; 2005 Dec; 192(12):2074-80. PubMed ID: 16288370
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of nasal clearance of nontypeable Haemophilus influenzae by oral immunization with outer membrane proteins.
Suzuki M; Kurono Y; Kodama S; Shigemi H; Mogi G
Acta Otolaryngol; 1998 Nov; 118(6):864-9. PubMed ID: 9870635
[TBL] [Abstract][Full Text] [Related]
10. Current status and potential application of ISCOMs in veterinary medicine.
Morein B; Hu KF; Abusugra I
Adv Drug Deliv Rev; 2004 Jun; 56(10):1367-82. PubMed ID: 15191787
[TBL] [Abstract][Full Text] [Related]
11. Cytosolic Delivery of Liposomal Vaccines by Means of the Concomitant Photosensitization of Phagosomes.
Hjálmsdóttir Á; Bühler C; Vonwil V; Roveri M; Håkerud M; Wäckerle-Men Y; Gander B; Johansen P
Mol Pharm; 2016 Feb; 13(2):320-9. PubMed ID: 26704885
[TBL] [Abstract][Full Text] [Related]
12. Transcutaneous immunization with an outer membrane protein of Porphyromonas gingivalis without adjuvant elicits marked antibody responses.
Koizumi Y; Kurita-Ochiai T; Yamamoto M
Oral Microbiol Immunol; 2008 Apr; 23(2):131-8. PubMed ID: 18279181
[TBL] [Abstract][Full Text] [Related]
13. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
[TBL] [Abstract][Full Text] [Related]
14. [The study for the immuno-protection of E. coli O157:H7 outer membrane protein].
Zhang Y; Lu SQ; Zhang YZ; Zhao BX; Xu JG
Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):58-62. PubMed ID: 14990161
[TBL] [Abstract][Full Text] [Related]
15. Iscom and iscom-matrix enhance by intranasal route the IgA responses to OVA and rCTB in local and remote mucosal secretions.
Ekström J; Hu KF; Bengtsson KL; Morein B
Vaccine; 1999 Jun; 17(20-21):2690-701. PubMed ID: 10418920
[TBL] [Abstract][Full Text] [Related]
16. The mucosal adjuvant effects of cholera toxin and immune-stimulating complexes differ in their requirement for IL-12, indicating different pathways of action.
Grdic D; Smith R; Donachie A; Kjerrulf M; Hörnquist E; Mowat A; Lycke N
Eur J Immunol; 1999 Jun; 29(6):1774-84. PubMed ID: 10382739
[TBL] [Abstract][Full Text] [Related]
17. Co-encapsulation of antigen and Toll-like receptor ligand in cationic liposomes affects the quality of the immune response in mice after intradermal vaccination.
Bal SM; Hortensius S; Ding Z; Jiskoot W; Bouwstra JA
Vaccine; 2011 Jan; 29(5):1045-52. PubMed ID: 21129393
[TBL] [Abstract][Full Text] [Related]
18. Transcutaneous immunization with a 40-kDa outer membrane protein of Porphyromonas gingivalis induces specific antibodies which inhibit coaggregation by P. gingivalis.
Maeba S; Otake S; Namikoshi J; Shibata Y; Hayakawa M; Abiko Y; Yamamoto M
Vaccine; 2005 Mar; 23(19):2513-21. PubMed ID: 15752838
[TBL] [Abstract][Full Text] [Related]
19. Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems.
Mohanan D; Slütter B; Henriksen-Lacey M; Jiskoot W; Bouwstra JA; Perrie Y; Kündig TM; Gander B; Johansen P
J Control Release; 2010 Nov; 147(3):342-9. PubMed ID: 20727926
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant modulation of the immune responses and the outcome of infection with Chlamydia pneumoniae.
Bandholtz L; Kreuger MR; Svanholm C; Wigzell H; Rottenberg ME
Clin Exp Immunol; 2002 Dec; 130(3):393-403. PubMed ID: 12452828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
